Pharmacists have a crucial role in providing extemporaneously compounded sterile preparations (CSPs) to patients and for ensuring the sterility, safety, and efficacy of these preparations.

Very effective standards are outlined in the United States Pharmacopeia (USP, Chapter 797) that serve as the foundation for sterile admixture programs; yet we know from two recent surveys of USP Chapter 797 compliance that the need for ongoing education and general acceptance of these standards remains significant.

In this webinar, Eric S. Kastango, MBA, RPh, FASHP reviews:

• Lessons still being learned from the tragic 2012 fungal meningitis outbreak, associated with thousands of vials of methylprednisolone that were compounded by a Massachusetts-based New England Compounding Pharmacy (NECC)